Overview

• The Royal Marsden reports detection of clinically significant prostate cancers rising from 27% to 52% after introducing a structured triage model.
• Average referral-to-MRI waiting time at the trust has fallen from nine days to three under the new pathway.
• Patients receive a detailed clinical history, physical examination and urinary assessment before MRI, with AI-assisted imaging used to improve diagnostic precision.
• Clinicians describe the approach as directing high-risk men rapidly to MRI and biopsy while filtering out low-risk or inappropriate cases earlier in the pathway.
• The UK still does not recommend universal PSA-based screening due to accuracy concerns, and charities say improvements like these bolster the case for targeted screening.